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Rat pancreatic islets and insulin-producing cells of the RINm5F line were incubated for 5 min at 7 or 23°C 
in media containing 3H,0 and either L-[l-W]glucose or [2-W]alioxan. In the islets the intracellular distri- 
bution space of [2-W]alloxan represented, at 7 and 23°C respectively, 11.4 f 1.0 and 25.5 f 2.3% of the 
intracellular 3H,0 space. In the RINm5F cells, the distribution space of [2-r4Clalloxan failed to be affected 
by the ambient temperature and represented, after correction for extracellular contamination, no more than 
5.2 t_ 0.5% of the intracellular “Hz0 space. Preincubation for 30 min at 7°C in the presence of alloxan 
(10 mM) failed to affect subsequent D-[U-14C]glucose oxidation in the tumoral cells, whilst causing a 70% 
inhibition of glucose oxidation in the islets. It is proposed that RINmSF cells are resistant o the cytotoxic 
action of alloxan, this being attributable, in part at least, to poor uptake of the diabetogenic agent. 
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1. INTRODUCTION 
Cultured tumoral insulin-producing cells of the 
RINm5F line are currently used for the study of 
biochemical and biophysical events associated with 
insulin secretion. These tumoral cells differ, 
however, from normal pancreatic B-cells by their 
poor secretory response to D-glucose [l-3]. Such 
a situation coincides with an abnormal pattern of 
glucose metabolism in the RINmSF cells [3,4]. We 
have recently observed that a major difference be- 
tween RINmSF and normal pancreatic B-cells con- 
sists in an impaired transport of hexose into the 
tumoral cells [5]. Thus, whereas the extracellular 
and intracellular concentrations of D-glucose 
rapidly reach close-to-equilibrium in normal B- 
cells [6], virtually no D-glucose accumulates in 
tumoral cells [5]. This unexpected finding led us to 
investigate whether the diabetogenic agent alloxan, 
which is thought to be transported into the normal 
* B-cell by the same carrier as that responsible for 
the transport of hexoses [7], also accumulates to a 
lesser extent in tumoral than in normal insulin- 
producing cells. This report indicates that tumoral 
cells indeed take up alloxan less efficiently than 
normal islet cells and that this coincides with a 
resistance of the RINmSF cells to the cytotoxic ac- 
tion of alloxan. 
2. MATERIALS AND METHODS 
Pancreatic islets prepared by the collagenase 
method from fed albino rats [8] and RINmSF cells 
cultured and harvested as described [9] were placed 
in 60 ~1 of a bicarbonate-buffered medium [S] con- 
taining bovine albumin (5 mg/ml). Groups of 20 
pancreatic islets or 3 x lo5 RINmSF cells were in- 
cubated for 5 min at either 7 or 23°C in the 
presence of either 3Hz0 and 2.0 mM L- 
[l-14C]glucose (control) or 3Hz0 and 10.0 mM 
[2-i4C]alloxan (alloxan). The distribution space of 
the labelled molecules was then measured as 
described in [lo]. In table 1, the distribution space 
of the 14C-labelled compounds, i.e. L- 
[ 1 -i4C]glucose in the control group and 
[2-‘4C]alloxan in the alloxan group, is expressed in 
percent of the paired ‘Hz0 space. 
For measuring the oxidation of glucose, the 
islets or cells were preincubated for 30 min at 7°C 
with or without alloxan (10 mM), washed once 
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with an alloxan-free medium, and eventually in- 
cubated for 60 min at 37°C in the sole presence of 
2.8 mM D-[U-‘4C]glucose [ll]. 
All results are expressed as the mean values 
(+ SE) together with the number of individual 
observations (in parentheses). The statistical 
significance of differences between mean values 
was assessed by the Student’s r-test. 
3. RESULTS 
To study the cellular uptake of alloxan, pan- 
creatic islets or tumoral cells were incubated for 
5 min, at 7 or 23”C, in media containing 3Hz0 and 
either L-[1-i4C]glucose or [2-14C]alloxan. The 
distribution space of L-[1r4C]glucose in either the 
islets or tumoral cells was slightly higher at 23 than 
7°C (table 1). The intracellular volume taken as the 
paired difference between the 3H~0 and L- 
[l-‘4C]glucose distribution spaces, averaged 4.68 + 
0.32 nl per islet and 1.14 + 0.05 pl per tumoral cell 
(n = 20 in each case; pooled data obtained at 7 and 
23°C). Whether at 7 or 23”C, the 3H~0 space was 
somewhat higher (P < 0.02) in islets exposed to 
alloxan (10 mM) than in control islets. Thus, in the 
presence of alloxan, the 3Hz0 space averaged 
124.7 +- 7.9% of the mean corresponding control 
value (100.0 f. 4.7%; n = 20 in each case). Our 
data do not allow one to decide whether this in- 
crease corresponds to an enlargement of the in- 
terstitial and/or the intracellular space(s). A com- 
parable phenomenon was not observed in the 
tumoral cells in which the 3H~0 space averaged, in 
the presence of alloxan, 104.5 +- 1.8% of the mean 
corresponding control value (100.0 + 2.0%; n = 20 
in both cases; P > 0.1). 
The distribution space of [2-r4C]alloxan exceed- 
ed that of L-[l-14C]glucose under all experimental 
conditions (table 1). In the RINmSF cells, the 
alloxan space was unaffected by a rise in 
temperature from 7 to 23°C. In the islets, however, 
the alloxan space was almost doubled in response 
to the same increase in temperature (table 1). By 
comparison of the data obtained, within each ex- 
periment, with L-[l-‘4C]glucose and [2-14C]allox- 
an, it was calculated that the intracellular distribu- 
tion space of [2-14C]alloxan, in the tumoral cells, 
did not exceed 5.24 f 0.47% of the intracellular 
space (n = 20, pooled data obtained at 7 and 
23’C). In the islets, however, the intracellular 
distribution space of [2-14C]alloxan amounted to 
11.35 -t 0.96% (at 7°C) and 25.48 f 2.28% (at 
23°C) of the intracellular space (n = 10 in each 
case). In comparing the results obtained in the 
islets and tumoral cells, it should be kept in mind 
that the true uptake of alloxan by normal B-cells is 
probably higher than suggested by our data, since 
alloxan is virtually excluded from non-B islet cells 
1121. 
The difference in alloxan uptake by tumoral and 
normal cells coincided with a difference in their 
sensitivity to the cytotoxic action of the 
diabetogenic agent, as assessed by their capacity to 
oxidize D-[U-i4C]glucose [ 131. Preincubation of 
the islets with alloxan (10 mM) for 30 min at 7°C 
resulted in a severe reduction (P < 0.001) in D- 
[U-‘4C]glucose oxidation (table 1). Under the same 
experimental conditions and, despite the high con- 
centration of alloxan used in these experiments, 
the diabetogenic agent failed to affect glucose ox- 
idation in the tumoral cells. 
Table 1 
Uptake and effect of alloxan in pancreatic islets and RINm5F 
Experimental Islets RINm5F cells 
conditions 
Control Alloxan Control Alloxan 
Distribution space of L-[1-r4C]glucose (control) or [2-‘4C]alloxan (alloxan) expressed in ‘J7o f 
3Hz0 space 
7°C 12.71 f 2.03 (10) 22.62 f 1.83 (10) 7.75 + 0.44 (10) 14.14 f 0.81 (10) 
23°C 16.84 f 1.91 (10) 38.03 +- 1.83 (10) 10.18 +_ 0.82 (10) 13.37 f 0.33 (10) 
D-[U-14C]Glucose oxidation (pmol/islet or lo3 cells per 60 min) 
37°C 2.92 f 0.11 (12) 0.89 f 0.05 (12) 5.55 k 0.13 (20) 5.62 f 0.17 (20) 
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4. DISCUSSION 
The present findings indicate that RINmSF cells 
are resistant to alloxan, and suggest that such a 
resistance is attributable, in part at least, to a poor 
uptake of the diabetogenic agent by the tumoral 
cells. This is consistent with the knowledge that the 
cellular accumulation of alloxan represents an 
essential, albeit not the sole, determinant of its 
cytotoxic action [14]. Incidentally, a modest up- 
take of alloxan by the RINSmF cells is not incom- 
patible with the integrity of glucose oxidation. In- 
deed, a restricted uptake of alloxan may not be 
sufficient to impair the function of islet cells. For 
instance, such a situation was already encountered 
in pancreatic islets exposed to alloxan in the 
presence of 3-O-methyl-D-glucose [ 151. 
In conclusion, when taken together with our 
prior observations on the uptake of hexoses by 
RINmSF cells [5], the present results reinforce the 
view that an impaired transport of hexoses and 
structurally related molecules represents a fun- 
damental defect of these tumoral, as distinct from 
normal, insulin-producing cells. 
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